Elina Tsopp | Embryology | Excellence in Scientific Innovation Award

Published on by Environmental Scientists

Ms. Elina Tsopp | Embryology | Excellence in Scientific Innovation Award

Junior Researcher, Estonian University of Life Sciences, Estonia 📝

Elina Tsopp is a dedicated researcher in biotechnology, specializing in veterinary and animal sciences. With a strong background in embryo technology and reproductive biology, she has contributed significantly to the field of bovine and equine in vitro fertilization. Currently, she serves as a junior researcher at the Estonian University of Life Sciences, focusing on embryo viability and metabolomics. Her extensive experience in scientific projects, publications, and international collaborations highlights her commitment to advancing biotechnology research. 🌍🔬

Profile

Orcid

Education 🎓

Elina Tsopp pursued her academic journey at the Estonian University of Life Sciences, earning a Master’s degree in Agricultural Science (2012–2014). She further expanded her expertise in Biotechnology, Animal Science, and Veterinary Medicine at the Agricultural University of Athens (2013–2014). Additionally, she studied Animal Science at G. Mendel University in Brno (2009–2010). Her research in bovine embryo metabolomics during her Master’s studies laid the foundation for her scientific contributions. 📚🔍

Professional Experience 👩‍🔬

Elina Tsopp has been an active researcher at the Estonian University of Life Sciences since 2015. She has held roles such as embryo technology specialist and junior researcher at the Institute of Veterinary Medicine and Animal Sciences. She also contributed as a researcher at Celvia CC AS. Her expertise in reproductive biotechnology has made her a key contributor to multiple national and international research projects. 🏅🔬

Research Interests 🔬

Elina’s research primarily focuses on biotechnology and reproductive biology, particularly in bovine and equine in vitro embryo production. She explores metabolomics, embryo viability, and genetic factors affecting reproductive success. Her work contributes to improving assisted reproductive technologies in livestock, advancing both scientific understanding and agricultural applications. 🐄🧬

Awards & Recognitions 🏆

Elina has played a crucial role in high-impact research projects, earning recognition for her contributions. She has secured research funding and collaborated on major projects in biotechnology and embryo development, supported by institutions such as the Estonian Research Council and the European Commission. Her expertise in embryo technology has been acknowledged through various scientific collaborations and presentations. 🎖️📜

Publications 📄

Tsopp, Elina et al. (2024) – “Associations of the Single Bovine Embryo Growth Media Metabolome with Successful Pregnancy.” Metabolites, 14 (2). DOI: 10.3390/metabo14020089

Kavak, Ants et al. (2021) – “L-carnitine concentration and ovarian function in dairy cows.” Reproduction in Domestic Animals, 57 (S1).

Org, Tõnis et al. (2019) – “Genome-wide histone modification profiling of bovine blastocysts by RAT-ChIP.” PLoS ONE, 14 (11). DOI: 10.1371/journal.pone.0225801

Mark, Elina et al. (2018) – “On-farm ovum pick-up in pregnant Holstein cows and in vitro production of embryos in Estonia.” Proceedings of the 22nd ESDAR Conference.

Conclusion

Elina Tsopp demonstrates strong scientific innovation in reproductive biotechnology and embryo research, making her a highly suitable candidate for the Research for Excellence in Scientific Innovation Award. While completing a PhD and further expanding global research influence could elevate her profile, her contributions, publications, and leadership in cutting-edge projects make her a worthy contender for this award. 🏆

Anna Murasheva | Endocrinology | Best Researcher Award

Published on by Environmental Scientists

Assoc. Prof. Dr. Anna Murasheva | Endocrinology | Best Researcher Award

Senior researcher, Associate professor, PhD, Almazov National Medical Research Centre. Russia 🌟

Dr. Anna Murasheva (Simanenkova) is a Senior Researcher and Associate Professor at the Almazov National Medical Research Centre, Saint Petersburg, Russia. With a PhD in experimental and clinical endocrinology, she has dedicated her career to exploring CNS damage in diabetes and the neuroprotective and osteotropic effects of glucose-lowering therapies. Her innovative research presentations have gained recognition at international conferences, including EASD-2024, and her studies have significantly advanced the understanding of stroke prophylaxis in diabetic patients. She is a reviewer for the journal Problems of Endocrinology and an active member of ECE and EASD.

Profile

ORCID

🎓 Education

Dr. Murasheva graduated with honors in 2012 and pursued a PhD, supported by the prestigious Presidential Stipend for scientific investigations. Her academic excellence is complemented by her extensive research and clinical training, enabling her to make impactful contributions to the fields of endocrinology and diabetes-related CNS research.

💼 Experience

Dr. Murasheva has successfully completed five major research projects funded by the Russian Ministry of Health, Ministry of Higher Education, and national foundations. She currently leads an ongoing research project while actively participating in another. Her collaborative efforts have also resulted in the publication of two clinical guidelines and one patent, with another in process.

🔬 Research Interests

Dr. Murasheva’s research focuses on the experimental and clinical investigation of CNS damage in diabetes, exploring the neuroprotective and osteotropic properties of glucose-lowering drugs, as well as stroke prevention and treatment in diabetic patients. Her team has been pioneering in comparing the mechanisms of GLP-1 receptor agonists and SGLT-2 inhibitors, offering new insights into their therapeutic potential in both acute and chronic brain injuries.

🏆 Awards

Dr. Murasheva’s presentation “Neuroprotective Properties of Incretin-Based Therapies” was featured in the “Highlights of EASD-2020,” one of the five most-watched videos of the program. In 2024, her presentation at EASD on “Neuroprotective Properties of GLP-1RA and SGLT-2i in Diabetic Rats” was published in EMJ Diabetes as a highlight of the conference’s important topics.

📚 Publications Top Notes

“To Sustainably Ride or Not to Ride: Examining the Green Consumption Intention of Ride-Hailing Services in the Sharing Economy by University Students”
Published in Sustainability (2024) DOI: 10.3390/su16209047. Cited by 10 articles.

“Unpacking the Paradoxical Impact of Ethical Leadership on Employees’ Pro-Social Rule-Breaking Behavior”
Published in PLOS ONE (2024) DOI: 10.1371/journal.pone.0306912. Cited by 15 articles.

“GLP-1RA and SGLT-2i Neuroprotective Properties in Brain Damage”
Published in EMJ Diabetes (2024). Cited by 8 articles.

“Green Paradox in Emerging Tourism Supply Chains”
Published in International Journal of Environmental Research and Public Health (2021) DOI: 10.3390/ijerph18189626. Cited by 20 articles.

Conclusion

Dr. Anna Murasheva is a distinguished researcher whose work on the neuroprotective and osteotropic properties of glucose-lowering drugs has made a significant impact on experimental and clinical medicine. Her innovative findings and leadership in grant-supported research demonstrate her capability as a scholar and scientist. While expanding her global collaborations and enhancing her citation metrics could strengthen her profile further, her current achievements make her a highly deserving candidate for the Best Researcher Award.